OLAPARIB - Uses Warnings Side Effects Precautions Overdose & Brands - Watsons Health

OLAPARIB

Bivalirudin

Olaparib is a drug that hinders poly ADP-ribose polymerase (PARP) enzymes such as PARP-1, PARP-2, and PARP-3, which are basic in the repair of damaged DNA, and in the regulation of cell cycles and DNA transcription in cancer cells.

Olaparib is used to treat cancer. Its tablets and capsules are used to treat ovarian cancer in women who had no improvement with other treatments.

Olaparib should not be given to women with the following conditions:

Olaparib may have the following side effects:

  • Bone marrow suppression
  • Dysgeusia
  • Peripheral oedema
  • Myalgia
  • Dizziness
  • Urinary incontinence
  • Vulvovaginal disease

Take extra caution in patients with the following medical conditions:

 

Interactions

Olaparib may interact with the following medicines:

  • Hormonal contraceptives
  • Moderate or severe CYP3A4 inducers
  • Moderate or strong CYP3A4 inhibitors
  • Other antineoplastic agents

If overdose is suspected, seek emergency medical help.

Available Brand:

  • Lynparza

 

Related Articles

HUMAN PAPILLOMAVIRUS 9-VALENT VACCINE

The 9-valent vaccine against the human papillomavirus (HPV) is a non-infectious adjuvanted vaccine made using recombinant technology. It contains inactive [...]

HUMAN PAPILLOMAVIRUS VACCINE (TYPE 6, 11, 16, 18)

The quadrivalent vaccine against the human papillomavirus (HPV) is a non-infectious adjuvanted vaccine made using recombinant technology. It contains inactive [...]

HIB CONJUGATE VACCINE (MENINGOCOCCAL PROTEIN CONJUGATE)

HiB Conjugate Vaccine (Meningococcal Protein Conjugate) induces the development of anticapsular antibodies, which protect against infection with Haemophilus influenzae type [...]